Aqsens Health’s Collaborative Research Receives Funding to Advance Saliva-Based Detection of Lung Cancer and Tuberculosis
Aqsens Health, a Turku-based medtech startup, announced in their newest press release a new collaboration with research teams from the Shanghai Jiao Tong University and Shanghai Public Health Clinical Center.
The company received funding from China’s Ministry of Science and Technology and Business Finland for a research collaboration focusing on the detection of lung cancer and tuberculosis from saliva samples.
The Chinese Ministry of Science and Technology (MOST) works in cooperation with the UN and European Union, among others, and focuses on supporting and encouraging innovation and collaboration between Chinese and international collaborators from various different fields.
“This project is a big step forward in bringing our E-TRF method and use of biosensors in detecting diseases from biological samples to the international research community,” says Timo Teimonen, CEO of Aqsens Health Ltd.